Lululemon 2Q Results Probably Won't Move the Needle
Dow Jones
Yesterday
824 ET - For Lululemon, second-quarter financial results likely won't move the needle much, Jefferies analysts say. The company is dealing with the same challenges as it has for the past several quarters, without significant positive or negative changes, the analysts say. Store checks have shown a return to normal product assortment with persistently sluggish brand momentum, as competitors including Alo and Vuori continue to take market share, the analysts say. Lululemon's new chief executive doesn't start until after the earnings report, so investors will be waiting to buy or sell until they hear her new plan, the analysts say.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.